New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
10:44 EDTCLVS, ITMN, DTV, ZU, JCPOptions with decreasing implied volatility: CLVS ITMN DTV ZU JCP
News For CLVS;ITMN;DTV;ZU;JCP From The Last 14 Days
Check below for free stories on CLVS;ITMN;DTV;ZU;JCP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 25, 2014
11:11 EDTITMNOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD ITMN AEO DKS WUBA URBN SPLS YOKU GME
10:54 EDTITMNHigh option volume stocks
Subscribe for More Information
10:40 EDTITMNBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
10:16 EDTJCPJ.C. Penney rises after analyst predicts more store closures coming
Subscribe for More Information
10:00 EDTITMNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:11 EDTITMNOn The Fly: Pre-market Movers
Subscribe for More Information
08:24 EDTITMNRoche to hold a conference call
CEO Schwan and CFO Hippe discuss the acquisition of InterMune on a conference call to be held on August 25 at 9 am. Webcast Link
07:37 EDTJCPJ.C. Penney recommneded as a Long Trade Idea at JPMorgan
Subscribe for More Information
07:11 EDTITMNInterMune volatility expected to move on Roche acquiring for $8.3B
Subscribe for More Information
06:39 EDTITMNInterMune downgraded to Hold from Buy at Stifel
Roche (RHHBY) is buying InterMune (ITMN) in a deal valued at $8.3B, or $74 per a share.
August 24, 2014
20:27 EDTITMNRoche drops pursuit for remainder of Japan's Chugai, Bloomberg says
Subscribe for More Information
13:41 EDTITMNRoche to acquire InterMune for $74.00 per share
Roche (RHHBY) and InterMune (ITMN) announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction. This corresponds to a total transaction value of $8.3B on a fully diluted basis. This offer represents a premium of 38% to InterMune's closing price on August 22 and a premium of 63% to InterMune's unaffected closing price on August 12. The merger agreement has been approved by the boards of InterMune and Roche. Under the terms of the merger agreement, Roche will commence a tender offer no later than August 29 to acquire all outstanding shares of InterMune common stock, and InterMune will file a recommendation statement containing the unanimous recommendation of the InterMune board that InterMune's shareholders tender their shares to Roche. The transaction is expected to be neutral to core earnings per share in 2015 and accretive from 2016 onwards. The acquisition of InterMune, a Brisbane, California based biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases, will allow Roche to broaden and strengthen its respiratory portfolio globally. Roche plans a smooth transition of InterMune employees and operations into the Roche organization, ensuring readiness for an expected launch of pirfenidone in the US in 2014. The closing of the transaction is expected to take place in 2014.
August 21, 2014
10:35 EDTJCPSears falls after reporting Q2 loss that more than doubled analyst projections
Subscribe for More Information
10:22 EDTJCPOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD VHC ACHN JCP WB JD YPF
10:14 EDTITMNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:22 EDTITMNInterMune downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded InterMune to Market Perform citing valuation.
August 20, 2014
11:42 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
05:53 EDTITMNStocks with implied volatility movement; NGD ITMN
Subscribe for More Information
05:51 EDTJCPStocks with implied volatility movement; JCP VHC
Subscribe for More Information
August 19, 2014
10:42 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use